Earnings Ahead

LPTX - Leap Therapeutics, INC.

3.23 0.16 5.21

  1. Home
  2. Healthcare
  3. LPTX
Leap Therapeutics, INC.

Leap Therapeutics, INC.

About

Profile

Headquarters

Massachusetts, United States

Intraday

High
-
Low
-

52-week

High
-
Low
-

LPTX



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Leap rebounds as Astellas posts Phase 3 data for rival cancer candidate
  • Leap Therapeutics falls after all-stock deal to acquire Flame Biosciences
  • Leap Therapeutics GAAP EPS of -$0.13 misses by $0.01
  • Leap Therapeutics GAAP EPS of -$0.15 misses by $0.05
  • Leap Therapeutics begins trials of DKN-01 in gastric/colorectal cancers
  • Leap Therapeutics GAAP EPS of -$0.09 beats by $0.01
  • Leap Therapeutics GAAP EPS of -$0.10 beats by $0.01, revenue of $0.38M beats by $0.08M
  • Leap Therapeutics forms partnership to develop companion diagnostic for cancer patients
  • Leap Therapeutics updates Phase 2 data for DKN-01 combo in GIT cancer
  • Leap Therapeutics EPS misses by $0.03, misses on revenue
  • Leap Therapeutics slips on pricing equity offering
  • MRIN, ALPN, SMMT and LPTX among after hours movers
  • Leap Therapeutics plunges on stock and pre-funded warrants offering
  • Leap Therapeutics stock jumps 47% on positive DKN-01 + tislelizumab data in gastroesophageal cancer
  • LAUR, LPTX, AERI and TWKS among after hours movers
  • Leap Therapeutics gains after announcing upcoming presentation for GIT cancer candidate
  • Leap Therapeutics EPS in-line, beats on revenue
  • Leap Therapeutics reports Q1 results
  • Flagship Biosciences and Leap Therapeutics ink RNAscope partnership
  • Leap Therapeutics stock surges on positive mid-stage DKN-01 data
PEERS
/XLV

XLV

Earnings History

Date EPS / Forecast Revenue / Forecast
August 13, 2021 -0.12 / -0.124 375K / 305K Beat!
May 14, 2021 -0.12 / -0.106 375K / 258.33K Beat!
March 12, 2021 -0.09 / -0.088 375K / 391.67K
November 12, 2020 -0.09 / -0.128 375K / 200K Beat!
August 13, 2020 -0.12 / -0.18 375K / 1.3M Beat!
May 14, 2020 -0.55 / -0.25 375K / 3M Beat!
March 27, 2020 - / -0.31 - / -
March 16, 2020 -0.33 / -0.32 - / - Beat!
November 18, 2019 - / -0.33 - / -
August 9, 2019 -0.37 / -0.43 375.0K / - Beat!
May 15, 2019 -0.47 / -0.41 375.0K / - Beat!
April 1, 2019 -0.21 / -0.57 - / -
November 9, 2018 -0.55 / -0.43 - / -
August 8, 2018 -0.5 / -0.49 - / -
May 11, 2018 -0.85 / -0.61 - / -
February 23, 2018 -0.65 / -0.82 - / -
November 10, 2017 -0.73 / -0.62 - / -
August 11, 2017 -0.74 / -0.61 - / -
Date Price Open High Low Vol Change ER
Mar 11 1.7400 1.8400
1.9000
1.7250
626.52K -0.57%
Mar 10 1.7500 1.7500
1.8000
1.7000
585.67K -3.85%
Mar 9 1.8200 1.7600
1.8400
1.7450
867.18K 5.20%
Mar 8 1.7300 1.7400
1.7950
1.5210
1.22M -0.57%
Mar 7 1.7400 1.7600
1.8463
1.7100
694.89K -3.87%
 
Mar 4 1.8100 1.8100
1.8800
1.7700
668.10K -2.69%
Mar 3 1.8600 1.9100
1.9794
1.8100
789.29K -1.59%
Mar 2 1.8900 1.9600
2.0100
1.8900
498.94K -3.08%
Mar 1 1.9500 1.9900
2.0800
1.9300
561.71K -2.01%
Feb 28 1.9900 1.9600
2.1199
1.9600
774.74K -0.5%
Feb 25 2.0000 2.0600
2.0600
1.9300
837.04K -1.96%
Feb 24 2.0400 1.7500
2.0450
1.7500
1.33M 5.70%
Feb 23 1.9300 2.0500
2.0750
1.9100
930.66K -4.93%
Feb 22 2.0300 2.0500
2.1100
2.0000
632.97K -2.87%
Feb 18 2.0900 2.1800
2.1800
2.0500
1.01M -2.79%
Feb 17 2.1500 2.2500
2.3700
2.1300
1.03M -6.52%
Feb 16 2.3000 2.3700
2.3850
2.2900
891.85K -4.17%
Feb 15 2.4000 2.2900
2.4500
2.2800
1.73M 7.14%
Feb 14 2.2400 2.1900
2.2800
2.1500
971.88K 1.36%